
Testosterone levels vary with age, health, body composition, binding proteins, and testing methods. An age-group average cannot show what one person should have or whether treatment is appropriate. Large studies also disagree with a simple fixed annual decline. Symptoms, repeated well-collected tests, and investigation of the cause remain more useful than comparing a result with an online age chart.123
Key points
- A cross-sectional age comparison is not a measurement of one person aging.1
- Weight and health changes can accompany changes in testosterone and SHBG.2
- Age alone does not establish a diagnosis or a reason for testosterone therapy.3
What does a testosterone-by-age chart actually describe?
An age chart usually describes people of different ages measured at one point or within one study period. The chart can show how a population is distributed. It cannot tell whether a particular younger participant will follow the average line as he grows older, or whether a lower reading reflects age, illness, body composition, or measurement differences.1
Some charts show means, others show medians, and others display laboratory reference limits. Those are different statistics. A mean is not a lower boundary of health, and a percentile is not a treatment target. A chart without its sample, assay, collection schedule, and definition of healthy is difficult to interpret.
Before comparing a personal result with an age bracket, identify what the bracket represents. This basic check is often more useful than debating a small difference between the reported value and an unsourced online average.
Does testosterone fall by the same percentage every year?
No fixed yearly percentage describes every man. Longitudinal studies follow individuals, while cross-sectional studies compare age groups, and the answers can differ. Health selection, obesity, medication use, and laboratory methods affect the observed trend.1 2
A 2023 individual participant data meta-analysis incorporated data from nine studies involving 21,074 men, plus aggregate data from two additional studies. The cross-sectional association of total testosterone with age was nonlinear, with little average change across ages 17-70 and a decline at older ages. This does not prove that individuals remain unchanged until age 70. It challenges the idea that one simple annual-loss formula can describe an entire population.1
Because the analysis was cross-sectional, its age pattern cannot be used to forecast a personal concentration. The appropriate inference is narrower: the relationship between age and measured testosterone is more complex than a straight descending line.
What happens when researchers follow the same men?
Following the same people over time better addresses hormone change within individuals, although observational follow-up still cannot isolate every cause. In the European Male Ageing Study, paired testosterone measurements were available for 2,395 men after a mean follow-up of about 4.4 years. Hormone changes were associated with weight changes as well as age.2
Men who lost weight tended to have increases in total testosterone and SHBG, while weight gain was associated with decreases. That finding does not provide a guaranteed testosterone response to a weight-loss plan or mean that every low result is caused by weight. It does show why a changing hormone value should be interpreted alongside changes in health and body composition.
A record of weight, illness, medication, sleep, and test conditions can therefore make a personal sequence of results more meaningful than comparing each result with a different internet chart.

Why do some laboratories use a young-adult reference range?
A reference population can be chosen to provide a stable comparison with healthy young adults. The often-cited 264-916 ng/dL interval was derived in healthy nonobese men aged 19-39 after harmonizing testosterone measurements. It was not created by averaging every male age group together.4
That explains a frequent misunderstanding: seeing a broad adult interval does not mean a laboratory has simply mixed teenagers and very old men into one undifferentiated sample. Laboratories can still differ in their methods and reference populations, so the specific report needs review.
The normal-levels guide separates reference intervals from diagnostic cutoffs. Neither a young-adult interval nor an age-specific interval can make a diagnosis without the clinical picture. A laboratory distribution cannot settle whether a particular symptom would improve with treatment.
Why might free testosterone change differently from total testosterone?
Total testosterone includes protein-bound hormone, so changes in SHBG can make its age pattern differ from that of free testosterone. A person may have a relatively stable total concentration while the unbound fraction changes. Conversely, a lower total value associated with low SHBG may not imply the same reduction in free hormone.3
This is one reason to avoid treating total testosterone as a complete biological age marker. Different studies measure or calculate free testosterone differently, and those methods have their own uncertainty. An apparent age effect can partly reflect the hormone fraction being studied.
For an individual with a borderline total result or suspected binding-protein changes, an appropriate free testosterone assessment may add useful information. It should answer a clinical question, rather than serve as another number to compare with the upper end of a younger age group's range.
How should different age-related evidence be used?
The evidence types below are useful for different purposes. Each design answers a different question about age and hormone concentrations.1 2 3 4
| Evidence | Useful for | Insufficient for |
|---|---|---|
| Cross-sectional age groups | Describing population differences 1 | Forecasting an individual annual decline |
| Longitudinal repeat measurements | Studying change within individuals 2 | Proving that age caused every change |
| Healthy young reference interval | Providing a standardized laboratory comparison 4 | Assigning a youthful treatment target |
| Clinical history plus repeat tests | Evaluating an individual with possible deficiency 3 | Assuming every nonspecific symptom is hormonal |
| Treatment trial in a selected population | Estimating effects in comparable patients | Promising prevention of aging in healthy people |

Should symptoms be dismissed as normal aging?
No. Persistent symptoms deserve evaluation at any adult age, but the explanation should not be assumed in advance. Low sexual desire, anemia, fractures, fatigue, and loss of function can have several causes. Age does not make those concerns unimportant, and it does not establish testosterone deficiency either.3
The assessment should ask whether symptoms and repeated biochemical findings align, whether another condition contributes, and whether there is a testicular, hypothalamic, or pituitary cause. Treating a recognized disorder is a different question from attempting to restore a number remembered from decades earlier.
The diagnostic guide lays out that sequence. It helps avoid two opposite errors: attributing every change to aging and attributing every change to testosterone. Both shortcuts can delay attention to the actual problem.
How should you interpret a result that is lower than it was years ago?
First establish whether the comparison is technically and clinically fair. Old and new samples may have different collection times, methods, units, or treatment contexts. A single earlier reading is also an uncertain estimate of the person's former baseline. These differences can create an apparent trend without demonstrating a sustained biological decline.3
If several comparable results show a change, the history becomes more useful. Record illness, medicines, weight, sleep, and symptoms over the same period. The longitudinal EMAS findings support considering these accompanying changes rather than assigning the entire difference to age.2
The question then becomes whether there is a current disorder needing investigation. It is not necessary to prove that every change came from aging, nor is a past higher value by itself a reason to restore that exact concentration. A personal timeline should sharpen the evaluation of present health, not replace it with a numerical target.
Do newer labeling announcements make age a treatment indication?
A labeling announcement should be read as the specific regulatory action it describes. FDA's current information page reports that in June 2026 it requested removal of an age-related limitation of use and revisions to other safety language. That is distinct from proving that testosterone reverses aging, and it does not show that every product label has already changed.5
The clinical question still concerns an individual's symptoms, confirmed hormone status, underlying condition, treatment goals, and risks. Chronological age alone supplies none of those answers. Nor does a chart establish how much benefit a person with normal hormone production would obtain from treatment.
When considering medication, use the actual current prescribing information for the product and a clinician's assessment. The purpose of an age chart is to understand evidence and variation, not to create a prescription threshold based on a birthday.
Common questions
Should I compare my result only with men my own age?
Does one lower result prove accelerated aging?
Can an older man naturally have a higher value than a younger man?
References
- 1.Marriott RJ, et al. Factors Associated With Circulating Sex Hormones in Men: Individual Participant Data Meta-analyses. Annals of Internal Medicine. 2023.
- 2.Camacho EM, et al. Age-Associated Changes in Hypothalamic-Pituitary-Testicular Function in Middle-Aged and Older Men Are Modified by Weight Change and Lifestyle Factors. European Journal of Endocrinology. 2013.
- 3.Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
- 4.Travison TG, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. Journal of Clinical Endocrinology & Metabolism. 2017.
- 5.US Food and Drug Administration. Testosterone Information. Updated 2026.
This article is for general education, not medical advice, diagnosis or a treatment recommendation. A licensed clinician can interpret the evidence in the context of your symptoms, tests, medicines and fertility plans.